Cyclopharm Limited (ASX: CYC) is pleased to announce it has successfully completed an institutional share placement of 8.5 million new fully paid ordinary shares at $1.15 per share raising $9.775 million before costs.
The issue price represents an 11.7% premium to CYC’s share price of $1.03 (based on closing price on 18 December 2019).
For more information, download the attached PDF.
Download this document
